We have previously compared 25-hydroxycholecalciferol levels in the serum of patients with osteoarthrosis and rheumatoid arthritis, finding no significant difference between the circulating levels of this hormone. We have now estimated 1,2.5-dihydroxycholecalciferol levels on stored sera from the same groups of patients and found no significant difference in the levels of this hormone between the 2 groups. The osteopenia that distinguishes rheumatoid arthritis from osteoarthrosis is not the result of altered levels of systemic 250HD3 or of 1,25(OH)2D3. Local factors may be more important in its pathogenesis.
SUMMARY
We have previously compared 25-hydroxycholecalciferol levels in the serum of patients with osteoarthrosis and rheumatoid arthritis, finding no significant difference between the circulating levels of this hormone. We have now estimated 1,2.5-dihydroxycholecalciferol levels on stored sera from the same groups of patients and found no significant difference in the levels of this hormone between the 2 groups. The osteopenia that distinguishes rheumatoid arthritis from osteoarthrosis is not the result of altered levels of systemic 
Results
There was no significant difference between the mean serum, 1,25(OH)2D3 level for the osteoarthrosis (OA) group (26X1 pg/ml) or for the rheumatoid arthritis (RA) group (27X9 pg/ml). A reduction in 1,25(OH)2D3 with age was seen in both groups and mirrored the reduction in 25-OHD3 previously observed. No significant differences were seen between sexes (RA, M/F = 29 6/27 0 pg/ml; OA, M/F = 26 6/25 9 pg/ml). When patients with RA were divided into those receiving steroids (n = 17) and those not receiving steroids (n = 13), no significant difference was seen in 1,25(OH)2D3 levels (mean = 29-2 pg/ml and 24-7 pg/ml respectively). 
